DNA Methylation Detection Technology Market Size was valued at USD 2.73 Bn in 2023 and is predicted to reach USD 7.85 Bn by 2031 at a 14.40% CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
DNA methylation detection technology analysis provides researchers with a wealth of information about gene regulation and the identification of possible biomarkers. Cancer, obesity, and addiction are just a few of the many diseases that have been connected to aberrant DNA methylation. Healthcare, biotechnology, pharmaceuticals, and research have all been profoundly impacted by the worldwide DNA methylation detection technology industry. Precision medicine has advanced thanks to these technologies, which have made it possible to identify epigenetic biomarkers linked to disease susceptibility, progression, and treatment response. This has allowed for the development of individualized treatment plans that consider each patient's genetic and epigenetic profiles. To provide safer and more effective treatments, DNA methylation analysis speeds up the process of discovering new drug targets, biomarkers for patient stratification, and predictors of medication response. In addition, clinical diagnostics are making greater use of these technologies for early disease detection, diagnosis, and prognosis. They offer excellent sensitivity and specificity, leading to better medical results.
However, the market growth is hampered by the lack of qualified professionals’ criteria for the safety and health of the DNA methylation detection technology market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or DNA methylation detection technology because of the absence of biotechnology specialists capable of conducting DNA methylation tests and research. The biotechnology industry shows encouraging signs with DNA methylation, but there is a severe shortage of trained lab staff to carry out these tests. Incorrect observations, faulty data interpretation, and incorrect conclusions could result from a lack of competence. Another factor that could slow the market's expansion is that DNA methylation is still not widely used as a diagnostic tool in the commercial sector. Restrictions on transportation caused by the COVID-19 outbreak hampered testing and research at academic institutions, which in turn had a detrimental effect on the market.
The DNA methylation detection technology market is segmented based on product, technology, application, and end user. Based on product, the market is segmented into consumables, instruments, and software. By technology, the market is segmented into polymerase chain reaction (PCR), microarray, sequencing, and other technologies. By application, the market is segmented into translational research and diagnostic procedures. By end user, the market is segmented into contract research organizations (CRO), research and academic laboratories, biopharmaceutical and biotech companies, and other end users.
The consumables segment is expected to hold a major global market share in 2022. Many consumables are needed to handle samples efficiently when using high-throughput technologies like microarray analysis and next-generation sequencing. In addition, the demand for consumables is anticipated to rise consistently, further establishing their market dominance as DNA methylation analysis continues to find more research and clinical applications.
The polymerase chain reaction (PCR)industry makes up the bulk of acrylic acid ester usage because it is reliable, flexible, and widely used. DNA methylation patterns can be detected with great sensitivity and specificity using PCR-based technologies like quantitative real-time PCR (qPCR) and methylation-specific PCR (MSP). These approaches are indispensable in epigenetics and clinical diagnostics, especially in countries like the US, Germany, the UK, China, and India.
The North American DNA methylation detection technology market is expected to register the highest market share in revenue in the near future. It can be attributed to the proliferation of product releases and approvals and the extensive network of manufacturing and research and development facilities. In addition, the increasing need for systems that express proteins has played a major role in expanding this area. In addition, Asia Pacific is projected to grow rapidly in the global DNA methylation detection technology market because the government is increasingly backing several programs. Additionally, a positive growth driver is the increasing attention of global businesses toward the expanding markets of the Asia Pacific region.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 2.73 Bn |
|
Revenue Forecast In 2031 |
USD 7.85 Bn |
|
Growth Rate CAGR |
CAGR of 14.40% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, By Application, By Technology, By End-user and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
New England Biolabs, Abcam plc., F. Hoffmann-La Roche Ltd., Thermo-Fisher Scientific Inc., Agilent Technologies Inc., BioRad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V., Illumina Inc., Pacific Biosciences Inc., Merck KGaA, PerkinElmer Inc., Enzo Life Sciences, Inc., Takara Bio Inc. and Hologic, Inc. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global DNA Methylation Detection Technology Market Snapshot
Chapter 4. Global DNA Methylation Detection Technology Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product:
5.2.1. Consumables
5.2.2. Instruments
5.2.3. Software
Chapter 6. Market Segmentation 2: By Technology Estimates & Trend Analysis
6.1. By Technology & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Technology :
6.2.1. Polymerase Chain Reaction (PCR)
6.2.2. Microarray
6.2.3. Sequencing
6.2.4. Other Technologies
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Application & Market Share, 2019-2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Application:
7.2.1. Translational Research
7.2.2. Diagnostic Procedure
Chapter 8. Market Segmentation 4: By End-User Estimates & Trend Analysis
8.1. By End-User & Market Share, 2019-2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type End-User:
8.2.1. Contract Research Organization (CRO)
8.2.2. Research and Academic Laboratories
8.2.3. Biopharmaceutical and Biotech Companies
8.2.4. Other End User
Chapter 9. DNA Methylation Detection Technology Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America DNA Methylation Detection Technology Market revenue (US$ Million) estimates and forecasts By Product, 2024-2031
9.1.2. North America DNA Methylation Detection Technology Market revenue (US$ Million) estimates and forecasts By Technology, 2024-2031
9.1.3. North America DNA Methylation Detection Technology Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
9.1.4. North America DNA Methylation Detection Technology Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
9.1.5. North America DNA Methylation Detection Technology Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
9.1.5.1. U.S.
9.1.5.2. Canada
9.2. Europe
9.2.1. Europe DNA Methylation Detection Technology Market revenue (US$ Million) by Product, 2024-2031
9.2.2. Europe DNA Methylation Detection Technology Market revenue (US$ Million) estimates and forecasts By Technology, 2024-2031
9.2.3. Europe DNA Methylation Detection Technology Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
9.2.4. Europe DNA Methylation Detection Technology Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
9.2.5. Europe DNA Methylation Detection Technology Market revenue (US$ Million) by country, 2024-2031
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific DNA Methylation Detection Technology Market revenue (US$ Million) by Product, 2024-2031
9.3.2. Asia Pacific DNA Methylation Detection Technology Market revenue (US$ Million) estimates and forecasts By Technology, 2024-2031
9.3.3. Asia Pacific DNA Methylation Detection Technology Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
9.3.4. Asia Pacific DNA Methylation Detection Technology Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
9.3.5. Asia Pacific DNA Methylation Detection Technology Market revenue (US$ Million) by country, 2024-2031
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America DNA Methylation Detection Technology Market revenue (US$ Million) by Product, 2024-2031
9.4.2. Latin America DNA Methylation Detection Technology Market revenue (US$ Million) estimates and forecasts By Technology, 2024-2031
9.4.3. Latin America DNA Methylation Detection Technology Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
9.4.4. Latin America DNA Methylation Detection Technology Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
9.4.5. Latin America DNA Methylation Detection Technology Market revenue (US$ Million) by country, (US$ Million) 2024-2031
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. Middle East & Africa
9.5.1. Middle East & Africa DNA Methylation Detection Technology Market revenue (US$ Million) by Product, (US$ Million)
9.5.2. Middle East & Africa DNA Methylation Detection Technology Market revenue (US$ Million) estimates and forecasts By Technology, 2024-2031
9.5.3. Middle East & Africa DNA Methylation Detection Technology Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
9.5.4. Middle East & Africa DNA Methylation Detection Technology Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
9.5.5. Middle East & Africa DNA Methylation Detection Technology Market revenue (US$ Million) by country, (US$ Million) 2024-2031
9.5.5.1. South Africa
9.5.5.2. GCC Countries
9.5.5.3. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Agilent Technologies, Inc.
10.2.2. Abcam plc.
10.2.3. Bio-Rad Laboratories, Inc.
10.2.4. Illumina, Inc.
10.2.5. Qiagen N.V.
10.2.6. Thermo Fisher Scientific, Inc.
10.2.7. F. Hoffmann-La Roche Ltd.
10.2.8. Hologic, Inc.
10.2.9. Pacific Biosciences of California, Inc.
10.2.10. Exact Sciences Corporation
10.2.11. Merck KGaA
10.2.12. Enzo Life Sciences, Inc.
10.2.13. Takara Bio Inc.
10.2.14. Revvity, Inc. (PerkinElmer, Inc.)
10.2.15. New England Biolabs
10.2.16. Other Prominent Players
DNA Methylation Detection Technology Market- By Product
DNA Methylation Detection Technology Market- By Technology
DNA Methylation Detection Technology Market- By Application
DNA Methylation Detection Technology Market- By End User
DNA Methylation Detection Technology Market- By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
